RocketLab vs. SpaceX: Why Smaller Rival May Offer Better Growth Upside

The Motley FoolThe Motley Fool
|||5 min read
Key Takeaway

SpaceX's $2 trillion June 2026 IPO faces slowing growth, while RocketLab's $37B valuation offers higher upside potential through Neutron development despite execution risks.

RocketLab vs. SpaceX: Why Smaller Rival May Offer Better Growth Upside

RocketLab vs. SpaceX: Why Smaller Rival May Offer Better Growth Upside

SpaceX's anticipated public debut in June 2026 at a staggering $2 trillion valuation has captivated investors, but a closer examination reveals that smaller competitor $RKLB (RocketLab) may present more compelling growth opportunities despite its own challenges. While SpaceX commands massive scale and market dominance, its decelerating growth trajectory and heavy reliance on government contracts create headwinds that could limit returns for new public shareholders. Meanwhile, RocketLab—valued at approximately $37 billion—is positioning itself as a leaner, more nimble alternative with significant expansion potential through its ambitious Neutron rocket program.

The contrast in growth momentum tells a revealing story about market dynamics in the commercial space sector. SpaceX's revenue growth decelerated sharply to 18% in 2025, down from 64% in 2024, signaling maturation in a company that has already captured substantial market share in satellite launch services. This slowdown reflects both the natural business cycle of a maturing enterprise and the limited addressable market for its current service offerings. For investors entering at a $2 trillion valuation—a staggering multiple of revenue and earnings—the margin of safety appears compressed. The company's heavy dependence on U.S. government contracts, particularly through NASA and the Department of Defense, also creates concentration risk that is difficult to quantify but increasingly relevant given political uncertainties surrounding key executives.

The Growth Differential and Neutron's Promise

RocketLab's strategic positioning offers a fundamentally different risk-return profile for investors seeking exposure to space infrastructure. The company is developing the Neutron rocket, an intermediary-lift vehicle designed to capture a significant portion of the growing satellite deployment and space station resupply market. This positions RocketLab in a niche between small-lift providers and heavy-lift leaders like SpaceX.

Key factors supporting RocketLab's investment thesis include:

  • Market opportunity: The global commercial space launch market is projected to expand substantially, with demand for mid-lift capacity growing faster than small-lift segments
  • Electron platform maturity: The company's existing Electron rocket is operational and generating revenue, providing a cash flow foundation
  • Neutron development: First orbital flight expected in coming years, with potential to unlock new customer segments and mission profiles
  • Valuation context: At $37 billion, the company trades at a lower multiple relative to projected revenues than SpaceX's $2 trillion ask

However, RocketLab faces substantial execution risks. The Neutron program has experienced delays, and the company's pre-revenue status for this platform means years of cash burn before meaningful contribution to profitability. Additionally, RocketLab's current valuation multiples are elevated relative to near-term earnings, pricing in substantial success assumptions.

Market Context: Competition and Regulatory Headwinds

The commercial space sector has transformed dramatically over the past decade, shifting from a government-only domain to include vibrant private competition. SpaceX created and dominates the reusable rocket market, achieving cost reductions that fundamentally altered industry economics. However, this very dominance may constrain future growth, as the addressable market for launch services—while large—is finite.

RocketLab operates in an increasingly crowded competitive landscape. Rivals include:

  • Axiom Space (developing commercial space stations)
  • Blue Origin (advancing New Glenn heavy-lift capabilities)
  • Relativity Space (pioneering 3D-printed rockets)
  • Chinese competitors like iSpace and OneSpace, which offer lower-cost alternatives

Regulatory factors add another layer of complexity. The Federal Aviation Administration (FAA) recently tightened licensing standards for commercial spaceports, affecting launch cadence. Additionally, ITAR regulations (International Traffic in Arms Regulations) restrict technology transfer and foreign partnerships, limiting growth options for U.S.-based companies.

Perhaps most significantly, political risks surrounding Elon Musk's activities and statements create uncertainty for SpaceX, whose business model depends on government contracts worth billions annually. Any shift in political dynamics or regulatory relationships could materially impact SpaceX's revenue trajectory and growth assumptions embedded in its $2 trillion valuation.

Investor Implications: Growth vs. Stability Trade-Off

For investors evaluating this choice, the decision hinges on risk tolerance and market outlook. SpaceX offers an entrenched market position, proven business model, and fortress-like competitive advantages. However, buying into a $2 trillion valuation at 18% growth offers limited margin of safety and requires confidence that the company can significantly expand addressable markets or achieve surprising margin expansion.

RocketLab presents a classic small-cap growth profile: higher volatility, execution risk, and valuation uncertainty, but substantially higher potential returns if the Neutron program succeeds and captures meaningful market share. The company's lower valuation multiple provides more room for multiple expansion if it executes effectively.

Key considerations for investors:

  • SpaceX entry timing: Buying at $2 trillion assumes limited upside unless the company can achieve significant revenue expansion or operate at substantially higher margins than currently realized
  • RocketLab execution: Success depends on Neutron's on-time development and market adoption; delays or technical setbacks could trigger significant repricing
  • Sector rotation: Institutional investor appetite for space-related assets may shift based on macro conditions and geopolitical developments
  • Government dependency: Both companies rely on government contracts, but SpaceX's concentration risk is higher

The broader market context matters significantly. Space infrastructure is increasingly viewed as essential to national security and economic competitiveness, supporting long-term demand. However, near-term market saturation in small-lift services and extended timelines for new revenue streams argue for patience and selective entry points.

Forward Outlook

Neither SpaceX nor RocketLab represents an obvious "better buy" in absolute terms; the choice depends entirely on investor profile and time horizon. SpaceX offers blue-chip stability with moderate growth in a high-revenue base. RocketLab offers higher-beta exposure to space infrastructure evolution with substantial upside if execution succeeds.

Investors should scrutinize both companies' capital efficiency, customer diversification, and technological roadmaps before committing capital. SpaceX's $2 trillion valuation demands exceptional execution and market expansion. RocketLab's $37 billion valuation offers more breathing room, but only if the company can demonstrate genuine progress on Neutron and convert its rocket platforms into sustainable, profitable operations.

The space sector's long-term fundamentals remain compelling, but valuations matter enormously for returns. As both companies approach or execute public transactions, disciplined investors should demand clarity on growth drivers, margin paths, and competitive defensibility before deciding which offers superior risk-adjusted returns.

Source: The Motley Fool

Back to newsPublished 2h ago

Related Coverage

Investing.com

Intel Surges on $25B Terafab AI Deal, Signals Foundry Strategy Vindication

Intel surges 4% after securing $25 billion Terafab AI chip partnership with SpaceX, Tesla, and xAI, validating foundry strategy and reversing negative sentiment.

AMZNGOOGGOOGL
Benzinga

Rocket Lab Stock Surges 5.47% on Completed $474M Offering and Analyst Upgrade

Rocket Lab stock jumped 5.47% Wednesday after completing a $474M equity offering and receiving a Citizens Bank upgrade to Market Outperform with an $85 price target.

RKLBXARARKQ
The Motley Fool

Wood's Contrarian Play: Ark Invest Loads Up on Beaten-Down Growth Stocks

Cathie Wood's Ark Invest bought shares of $HOOD, GeneDX, and $TSLA despite steep YTD declines, doubling down on growth bets amid market weakness.

TSLAHOODWGS
Benzinga

Mag 7 Stocks Soar on Iran Ceasefire as Growth Rally Resumes

Magnificent Seven tech stocks surged Wednesday as Iran ceasefire eased geopolitical tensions, with Meta jumping 5% and peers gaining 3-4.5%. Nasdaq futures rose 3.55%.

NVDAMETAMSFT
The Motley Fool

Rivian and Oklo Emerge as Decade-Long Plays on AI-Driven Transformation

Rivian and Oklo positioned as long-term growth stocks leveraging AI boom. Rivian trades at 3.2x sales with autonomous tech focus; Oklo offers small reactor energy infrastructure play.

OKLOTSLARIVN
Investing.com

S&P 500 Breaks Above 6620, Signals New Recovery Phase With Momentum Building

S&P 500 breaks above 6620, exiting diagonal formation with targets at 6894-6970. Support critical at 6640; downside risk at 5650.

NVDAMETAAMZN